Sign in

Lon Ensler

Chief Financial Officer at Momentus
Executive

About Lon Ensler

Lon Ensler is Chief Financial Officer of Momentus Inc., appointed effective August 1, 2025, after serving as Interim CFO from April 2, 2024; he is currently the principal financial and accounting officer . He has 30+ years of finance leadership experience across medical devices and high‑tech capital equipment, including CFO roles at Ziteo Medical (2019–2024) and Xradia (2008–2015), and advisory CFO work via Ensler Consulting (2015–2019); he was 66 at appointment as CFO . Education reported externally: B.S. and MBA in Finance from California State University, Northridge . Company-level pay-versus-performance disclosures reference relationships between compensation and TSR and net income, but do not provide Ensler-specific performance metrics .

Past Roles

OrganizationRoleYearsStrategic Impact
Ziteo Medical, Inc.Chief Financial Officer2019–Mar 2024 Led finance at developer of next-gen molecular imaging medical devices
Ensler ConsultingAdvisory/Consulting CFOJun 2015–Feb 2019 Provided interim CFO and advisory services to multiple companies
Xradia, Inc.Chief Financial Officer2008–2015 Finance leadership at high-tech capital equipment provider

External Roles

OrganizationRoleYearsNotes
EchoPixelCFONot disclosedExternal profile lists CFO role
Lyncean TechnologiesCFONot disclosedExternal profile lists CFO role

No public company directorships disclosed in Momentus filings .

Fixed Compensation

ComponentTermsEffective DateNotes
Base salary (CFO)$375,000 per yearAug 1, 2025Per Employment Agreement summary
Target annual cash bonus (CFO)50% of base salaryAug 1, 2025Per Employment Agreement summary
Interim CFO compensation$340 per hourApr 2, 2024Appointment as Interim CFO; age 65 at announcement

Performance Compensation

  • No CFO-specific annual performance metrics (e.g., weighting, targets) were disclosed in the Aug 6, 2025 8‑K summary; only target bonus eligibility was specified .
  • Company proxies describe non‑equity incentive plan compensation for NEOs as fixed annual bonuses tied to pre‑determined, measurable company milestones for 2023–2024, but this disclosure did not include Ensler as a NEO in those years .

Equity Ownership & Alignment

ItemDetailAs-of Date/GrantNotes
RSU grant (CFO)95,000 RSUsAug 1, 2025Reported on Form 4; a standard equity award
RSU sizing basisRepresents 1% of outstanding shares on grant dateAug 1, 2025Per Employment Agreement summary
Vesting schedule25% on each of the first four anniversaries of grantAug 1 in 2026, 2027, 2028, 2029Time-based vesting; no performance condition disclosed
Beneficial ownership (shares)— (less than 1%)May 9, 2024No reported beneficial holdings
Beneficial ownership (shares)— (less than 1%)Apr 3, 2025No reported beneficial holdings
Beneficial ownership (shares)— (less than 1%)Jul 22, 2025No reported beneficial holdings
Beneficial ownership (shares)— (less than 1%)Oct 10, 2025No reported beneficial holdings
  • Stock ownership guidelines: Executive officers are expected to hold stock equal to 3x base salary, to be met within five years of first becoming subject to the guidelines (administered by the Compensation Committee) .
  • Hedging/pledging: Insider Trading Policy prohibits hedging transactions; equity awards are nontransferable and may not be sold or pledged unless otherwise determined by the Administrator .
  • Clawback: Equity awards are subject to the company’s clawback policy and potential reduction/cancellation/recoupment per plan terms and applicable law .

Employment Terms

ProvisionTerms
Employment AgreementEffective August 1, 2025; governs CFO employment
Severance (non‑CoC)Accrued benefits; severance payments of 6 months base salary plus annual cash bonus in effect immediately prior to termination (prorated based on days elapsed in the calendar year); accelerated vesting of RSUs
Change‑of‑controlThe 8‑K summary references severance benefits and accelerated vesting but does not enumerate additional CoC multiples for Ensler; full terms are in Exhibit 10.1
OtherNo family relationships or Item 404(a) related-party interests; at‑will employment context implied by Momentus practices in proxies for other NEOs

Performance & Track Record

  • Certifications and filings: Ensler signed Sarbanes‑Oxley Section 906 certifications for the FY2024 10‑K/A and the Q2 FY2024 10‑Q, and signed the FY2024 10‑K and multiple 8‑Ks as principal financial officer, indicating active oversight of reporting and controls .
  • Background achievements: External profiles note prior finance leadership contributing to strategic transactions (e.g., Xradia sale to ZEISS) and extensive high‑tech finance experience .
  • Pay vs performance context: Company disclosed relationships between compensation actually paid and TSR/net income but did not provide Ensler‑specific metrics .

Board Governance

  • Ensler is an executive officer (CFO), not listed as a director in proxies; director independence and committee frameworks described in filings are not specific to Ensler .

Compensation Committee Analysis

  • Stock Ownership Guidelines for executives (3x base salary, five‑year compliance window) indicate alignment expectations; hedging is prohibited; clawback policy applies broadly to equity awards .

Investment Implications

  • Alignment: A sizable, time‑based RSU grant sized at ~1% of outstanding shares with four‑year ratable vesting aligns Ensler’s incentives with equity value realization, while also creating predictable vesting events that can translate into periodic supply if monetized .
  • Retention: Severance terms (6 months base + prorated bonus and accelerated RSU vesting) provide downside protection but are moderate compared to CEO‑level constructs, suggesting retention levers rely more on equity vesting than cash severance .
  • Ownership build: The executive stock ownership guideline (3x salary within five years) requires meaningful accumulation; current filings show no beneficial holdings for Ensler as of multiple 2024–2025 dates, implying a multi‑year ramp to guideline compliance primarily through RSU vesting and potential open‑market accumulation .
  • Trading signals: The disclosed RSU grant and annual vest schedule provide clear dates for potential insider selling pressure if shares are sold upon vest; hedging prohibitions and equity nontransferability reduce misalignment risks tied to derivatives or pledging .